Vaccination of influenza a virus decreases transmission rates in pigs

Veterinary Research

Volumn 42, Issue 1, 2011, Pages

  Romagosa, Anna ^a   Allerson, Matt ^a   Gramer, Marie ^a   Joo, Han ^a   Deen, John ^a   Detmer, Susan ^a   Torremorell, Montserrat ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA A VIRUS; INFLUENZAVIRUS A; ORTHOMYXOVIRIDAE; SUIDAE;

INACTIVATED VACCINE; INFLUENZA VACCINE; VIRUS ANTIBODY;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC REASSORTMENT; IMMUNOLOGY; INFLUENZA VIRUS A H1N1; LUNG; NOSE; ORTHOMYXOVIRUS INFECTION; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; SWINE; SWINE DISEASE; VIROLOGY;

ANIMALS; ANTIBODIES, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; LUNG; NOSE; ORTHOMYXOVIRIDAE INFECTIONS; REASSORTANT VIRUSES; SWINE; SWINE DISEASES; VACCINES, INACTIVATED;

EID: 84858130490     PISSN: 09284249     EISSN: 12979716     Source Type: Journal    
DOI: 10.1186/1297-9716-42-120     Document Type: Article

References (58)

1. 1). Madec F, Gourreau JM, Kaiser C, Vigouroux F, Salingardes F, Prime D, J Rech Porcine 1983 15 419 430 (in French)
2. Swine Influenza: Immunological, virological and clinical studies of experimental infections. Renshaw HW, MS thesis University of Wisconsin, Madison, WI 1970
3. Swine Influenza: I. Experimental transmission and pathology. Shope RE, J Exp Med 1931 54 349 359 10.1084/jem.54.3.349 19869922
4. Interaction between Mycoplasma hyopneumoniae and swine influenza virus. Thacker EL, Thacker BJ, Janke BH, J Clin Microbiol 2001 39 2525 2530 10.1128/JCM.39.7.2525-2530.2001 11427564 (Pubitemid 32606228)
5. Porcine respiratory coronavirus mediated interference against influenza virus replication in the respiratory tract of feeder pigs. Van Reeth K, Pensaert MB, Am J Vet Res 1994 55 1275 1281 7802396
6. The emergence of novel swine influenza viruses in North America. Olsen CW, Virus Res 2002 85 199 210 10.1016/S0168-1702(02)00027-8 12034486 (Pubitemid 34606914)
7. Multiple lineages of antigenically and genetically diverse influenza A virus co-circulate in the United States swine population. Webby RJ, Rossow K, Erickson G, Sims Y, Webster R, Virus Res 2004 103 67 73 10.1016/j.virusres.2004. 02.015 15163491 (Pubitemid 38649062)
8. Emergence of H3N2 reassortant influenza A viruses in North American pigs. Zhou NN, Senne DA, Landgraf JS, Swenson SL, Erickson G, Rossow K, Liu L, Yoon KJ, Krauss S, Webster RG, Vet Microbiol 2000 74 47 58 10.1016/S0378-1135(00) 00165-6 10799777 (Pubitemid 30224643)
9. Influenza in pigs and their role as intermediate host. Scholtissek CV, Hinshaw S, Olsen CW, In Textbook of Influenza Oxford United Kingdom, Blackwell Science, Nicholson KG, 1998 137 145
10. Part II: Reference of swine health and health management in the United States in 2006. USDA, NAHMS swine 2006 2006 National Animal Health Monitoring System, [on line]. http://www.aphis.usda.gov/animal-health/nahms/swine/ downloads/swine2006/Swine2006-dr-PartII.pdf, pp.17-20 [Consulted 30 November 2010]
11. Failure of protection and enhanced pneumonia with a US H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine. Vincent AL, Lager KM, Janke BH, Gramer MR, Richt JA, Vet Microbiol 2008 126 310 323 10.1016/j.vetmic.2007.07.011 17719188 (Pubitemid 350199605)
12. Efficacy of swine influenza A virus vaccine against an H3N2 virus variant. Lee JH, Gramer MR, Joo HS, Can J Vet Res 2007 71 207 212 17695596 (Pubitemid 47162402)
13. Efficacy of vaccination of pigs with different H1N1 swine influenza viruses using a recent challenge strain and different parameters of protection. Van Reeth K, Labarque G, De Clercq S, Pensaert M, Vaccine 2001 19 4479 4486 10.1016/S0264-410X(01)00206-7 11483274 (Pubitemid 32718672)
14. The concept of herd immunity and the design of community-based immunization programmers. Anderson RM, Vaccine 1992 10 928 935 10.1016/0264-410X(92)90327-G 1471414
15. Comparison of transmission of Mycoplasma hyopneumoniae in vaccinated and non-vaccinated populations. Meyns T, Dewulf J, de Kruif A, Calus D, Haesebrouck F, Maes D, Vaccine 2006 24 7081 7086 10.1016/j.vaccine.2006.07.004 16934376 (Pubitemid 46107205)
16. Experimental quantification of vaccine-induced reduction in virus transmission. de Jong MCM, Kimman TG, Vaccine 1994 12 761 765 10.1016/0264-410X(94)90229-1 8091855 (Pubitemid 24182379)
17. Determination of the onset of the herd immunity induced by the E2 sub-unit vaccine against classical swine fever virus. Bouma A, De Smit AJ, De Jong MCM, De Kluijver EP, Moormann RJM, Vaccine 2000 18 1374 1381 10.1016/S0264-410X(99)00398-9 10618535 (Pubitemid 30017850)
18. Design and analysis of an Actinobacillus pleuropneumoniae transmission experiment. Velthuis AGJ, De Jong MCM, Kamp EM, Stockhofe N, Verheijden JHM, Prev Vet Med 2003 60 53 68 10.1016/S0167-5877(03)00082-5 12900149 (Pubitemid 36996563)
19. 0. Kluivers M, Maurice H, Vyt P, Koenen F, Nielen M, Vet Res 2006 37 757 766 10.1051/vetres:2006035 16973116 (Pubitemid 44884287)
20. A quantitative assessment of the effectiveness of PRRSV vaccination in pigs under experimental conditions. Nodelijk G, de Jong MCM, van Leengoed L, Wensvoort G, Pol JMA, Steverink P, Verheijden JH, Vaccine 2001 19 3636 3644 10.1016/S0264-410X(01)00099-8 11395197 (Pubitemid 32522761)
21. Estimation of hepatitis E virus transmission among pigs due to contact-exposure. Bouwknegt M, Frankena K, Rutjes SA, Wellenberg GJ, de Roda Husman AM, van der Poel HM, de Jong MC, Vet Res 2008 39 40 10.1051/vetres: 2008017 18367077
22. Quantification of porcine circovirus type 2 (PCV-2) within-and between-pen transmission in pigs. Andraud M, Grasland B, Durand B, Cariolet R, Jestin A, Madec F, Rose N, Vet Res 2008 39 43 10.1051/vetres:2008020 18413131
23. Foot and mouth disease transmission among vaccinated pigs after exposure to virus shedding pigs. Orsel K, de Jong MCM, Bouma A, Stegeman JA, Dekker A, Vaccine 2007 25 6381 6391 10.1016/j.vaccine.2007.06.010 17658199 (Pubitemid 47096753)
24. On the definition and computation of the basic reproduction ratio Ro in models for infectious diseases in heterologous populations. Dieckman O, Heesterbeek JA, Metz JA, J Math Biol 1990 28 365 82 2117040
25. Design and analysis of small-scale transmission experiments with animals. Velthius AG, Bouma A, Katsma WE, Nodelijk G, de Jong MCM, Epidemiol Infect 2007 135 207 217
26. Quantification of the spread of Mycoplasma hyopneumoniae in nursery pigs using transmission experiments. Meyns T, Maes D, Dewulf J, Vicca J, Haesebrouck F, de Kruif A, Prev Vet Med 2004 66 265 275 10.1016/j.prevetmed.2004.10.001 15579347 (Pubitemid 39569146)
27. An E2 sub-unit marker vaccine does not prevent horizontal or vertical transmission of classical swine fever virus. Dewulf J, Laevens H, Koenen F, Mintiens K, de Kruif A, Vaccine 2002 20 86 91
28. The effects of strain heterology on the epidemiology of equine influenza in a vaccinated population. Park AW, Wood JL, Daly JM, Newton JR, Glass K, Henley W, Mumford JA, Grenfell BT, Proc Biol Sci 2004 271 1547 1555 10.1098/rspb.2004.2766 15306299 (Pubitemid 38998754)
29. Mathematical modeling of the pandemic H1N1 2009. World Health Organization, http://www.who.int/wer Weekly epidemiological record, 21 August 2009, 84rd year
30. Quantification of the effect of vaccination on transmission of avian influenza (H7N7) in chickens. Van der Goot JA, Koch G, de Jong MCM, van Boven M, Proc Natl Acad Sci 2005 102 18141 18146 10.1073/pnas.0505098102 16330777 (Pubitemid 41798515)
31. The effect of inoculation dose of a highly pathogenic avian influenza virus strain H5N1 on the infectiousness of chickens. Spekreijse D, Bouma A, Stegeman JA, Koch G, de Jong MC, Vet Microbiol 2011 147 59 66 10.1016/j.vetmic.2010.06.012 20619974
32. Estimation of transmission parameters of H5N1 Avian Influenza virus in chickens. Bouma A, Claassen I, Natih K, Klinkenberg D, Donnelly CA, Koch G, van Boven M, PLoS Pathog 2009 5 1000281 10.1371/journal.ppat.1000281
33. A single vaccination of commercial broilers does not reduce transmission of H5N1 highly pathogenic avian influenza. Poetri O, Bouma A, Claassen I, Koch G, Soejoedono R, Stegeman A, van Boven M, Vet Res 2011 42 74 10.1186/1297-9716-42-74 21635732
34. Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine. Vincent AL, Ma W, Larger KM, Janke BH, Webby RJ, Garcia-Sastre A, Richt JA, Vaccine 2007 25 7999 8009 10.1016/j.vaccine.2007. 09.019 17933442 (Pubitemid 350011004)
35. Evaluation of hemagglutinin subtype 1 influenza viruses from the United States. Vincent LA, Larger KM, Ma W, Lekcharoensuk P, Gramer MR, Loiacono C, Richt JA, Vet Microbiol 2006 118 212 222 10.1016/j.vetmic.2006.07.017 16962262 (Pubitemid 44781158)
36. Characterization of a newly emerged genetic cluster of H1N1 and H1N2 swine influenza virus in the United States. Vincent LA, Ma W, Lager KM, Gramer MR, Richt JA, Janke BH, Virus Genes 2009 39 176 185 10.1007/s11262-009-0386-6 19597980
37. Canine Kidney cell line for isolation of respiratory virus. Meguro H, Bryant JD, Torrence AE, Wright PF, J Clin Microbiol 1979 9 175 179 219021 (Pubitemid 9123778)
38. Development of a real time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hamagglutinin subtypes. Spackman E, Senne DA, Myers TJ, Bulaga LL, Garber LP, Perdue ML, Lohman K, Daum LT, Suarez DL, J Clin Microbiol 2002 40 3256 32560 10.1128/JCM.40.9.3256-3260.2002 12202562 (Pubitemid 34977437)
39. A laboratory manual for the isolation, identification, and characterization of avian pathogens. Villegas P, Alvarado I, American Association of Avian Pathologists, Jacksonville, FL, Dufour-Zavala L, Swayne DE and Glisson JR, 5 2008 218
40. Hemagglutination-inhibition test for avian influenza virus subtype identification and the detection and quantitation of serum antibodies to the avian influenza virus. Pedersen JC, Methods Mol Biology 2008 436 53 66 10.1007/978-1-59745-279-3-8
41. Comparison of the pathogenicity of two US porcine reproductive and respiratory syndrome virus isolates with the Lelystad virus. Harbur PG, Paul PS, Frey ML, Landgraf J, Eernisse K, Meng XJ, Lum MA, Andrews JJ, Rathje JA, Vet Pathol 1995 32 648 660 10.1177/030098589503200606 8592800
42. Pathogenic and antigenic properties of phylogenetically distinct reassortant H3N2 swine influenza viruses cocirculating in the United States. Richt JA, Lager KM, Janke BH, Woods RD, Webster RG, Webby RJ, J Clin Microbiol 2003 41 3198 3205 10.1128/JCM.41.7.3198-3205.2003 12843064 (Pubitemid 36842322)
43. Repeated measures analysis of binary outcomes: applications to injury research. Williamson DS, Bangdiwala SI, Marshall SW, Wa;ker AE, Accid Anal Prev 1996 28 571 579 10.1016/0001-4575(96)00023-1 8899038 (Pubitemid 126359262)
44. Bailey NTJ, The mathematical theory of infectious diseases and its applications London: Griffin 1975
45. Becker NG, Analysis of infectious disease data New York: Chapman and Hall 1989
46. A general method for numerically simulating the stochastic time evolution of coupled chemical reactions. Gillespie DT, J Comput Phys 1976 22 403 434 10.1016/0021-9991(76)90041-3 (Pubitemid 8008311)
47. Systemic and mucosal isotype-specific antibody responses in pigs to experimental Influenza A virus infection. Heinen PP, van Nieuwstadt AP, Pol JM, de Boer-Luijtze EA, van Oirschot JT, Bianchi ATJ, Viral Immunol 2000 13 237 247 10.1089/vim.2000.13.237 10893003 (Pubitemid 30419201)
48. Detection of anti-influenza A nucleoprotein antibodies in pigs using a commercial influenza epitope-blocking enzyme-linked immunosorvent assay developed for avian species. Ciacci-Zanella JR, Vincent AL, Prickett JR, Zimmerman SM, Zimmerman J, J Vet Diagn Invest 2010 22 3 9 10.1177/ 104063871002200102 20093676
49. Mathematical modeling in veterinary epidemiology: why model building is important. de Jong M, Prev Vet Med 1995 25 183 193 10.1016/0167-5877(95)00538-2
50. Design and analysis of transmission experiments. Kroese AH, de Jong MCM, Proceedings of the Society of Veterinary Epidemiology. Vet Epi Prev Med 2001 17
51. Comparison of two pseudorabies virus vaccines that differ in capacity to reduce virus excretion after a challenge infection, in their capacity of reducing transmission of pseudorabies virus. Bouma A, De Jong MC, Kimman TG, Vet Microbiol 1997 54 113 122 10.1016/S0378-1135(96)01271-0 9057255 (Pubitemid 27110073)
52. Efficacy of commercial swine influenza vaccines against challenge with a recent European H1N1 field isolates. Kyriakis CS, Gramer MR, Marbe F, Van Doorsselaere, Van Reeth K, Vet Microbiol 2010 144 67 74 10.1016/j.vetmic.2009. 12.039 20116942
53. Analysis of the quality of protection induced by a porcine influenza A vaccine to challenge with an H3N2 virus. Heinen PP, Nieuwstadt AP, de Boer-Luijtze EA, Bianchi AT, Vet Immuno Immunopathol 2001 82 39 56 10.1016/S0165-2427(01)00342-7 (Pubitemid 32823555)
54. Efficacy of inactivated swine influenza virus vaccines against the 2009A/H1N1 influenza virus in pigs. Vincent AL, Ciacci-Zanella JR, Lorusso A, Gauger PC, Zanella EL, Kehrli ME, Janke BH, Lager KM, Vaccine 2010 28 2782 2787 10.1016/j.vaccine.2010.01.049 20132919
55. Antibodies to the strain-specific and cross-reactive determinants of the hemagglutinin of influenza H3N2 viruses. Haaheim LR, Schild GC, Acta Pathol Microbiol Scand B 1980 88 335 340 6164247
56. Comparative study of the immunostimulatory properties of different adjuvants administered with an inactivated influenza virus vaccine and evaluation of passive immunity in pigs. Bikour MG, Cornaglia EM, Elazhary YC, Immunol Infect Dis 1994 4 400 407
57. Efficacy of equine influenza vaccines for protection against A/Equine/Jilin/89 (H3N8)-a new equine influenza virus. Webster RG, Thomas TL, Vaccine 1983 11 987 993
58. Silent spread of H5N1 in vaccinated poultry. Savill NJ, St Rose SG, Keeling MJ, Woolhouse MEJ, Nature 2006 442 757 10.1038/442757a 16915278 (Pubitemid 44258902)